Build · IQVIA

Fast-Tracking Clinical Trials

Eli LillyBuildIQVIA

Eli Lilly needed a scalable way to extract summary statistics from oncology and diabetes trials across clinical trial databases (ClinicalTrials.gov and TrialTrove). IQVIA deployed its NLP platform to address this, achieving "reduce costs, time and errors by speeding up research, and increasing precision and recall of data extracted." No further quantified metrics are given on the visible page; fuller detail is gated behind a PDF download.

IQVIA is the largest combined real-world-data and commercial-intelligence company in healthcare — its legacy IMS prescription and claims data underpins much of the industry's analytics.

This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.

Source

Published by IQVIA on its own site — read the original case study on iqvia.com ↗